Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated Financial Result along with Limited Review Report of the company for the quarter and Half year ended September 30, 2026 and any other businesses with the permission of the Chair.

VIVANZA BIOSCIENCES LIMITED Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. Phone: 079-26870953, email: info@vivanzabiosciences.com, website: www.vivanzabiosciences.com CIN: L24105GJ1982PLC005057 Date: 28th October,2026 Department of Corporate Services, BSE Limited, Ground Floor, P. J. Towers, Dalal Street, Mumbai – 400001, Scrip Code: 530057 ISIN: INE984E01035 Subject: Intimation for the meeting of the Board of Directors pursuant to Regulation 29, 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29, 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 03rd, 2026, at 03:30 P.M. at the Registered Office of the Company to consider and approve the following items: 1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter and Half year ended September 30, 2026; 2. Any other business with the permission of the chair; As per Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Intimation of the Board meeting would be made available on the website of the company at: https://vivanzabiosciences.com/announcement/ Further, as already informed, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, and Company's Internal Code for Prohibition of Insider Trading ('Code'), the trading window for dealing in the securities of the Company for the Directors/Officers & Key Managerial Personnel and Designated Persons of the Company defined under the Code has already been closed till the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter and Half year ended 30th September, 2026. We request you to take the same on record. Thanking you For Vivanza Biosciences Limited JAYENDRA MEHTA MANAGING DIRECTOR DIN: 08210602